Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
96-Hour Paclitaxel Infusion + Cisplatin in Advanced NSCLC
NCT00001450Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Primary endpoint: Overall Response Rate. Started Sep 1995; status: completed.
02
Drugs
paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00001450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001450.